In the Mix: 3 More Articles — May 24, 2026
This article discusses cannabinoid pharmaceutical financial challenges impacting drug development in 2026. It highlights the economic struggles of companies developing cannabinoid therapies. Understanding these challenges is essential for clinicians…
In the Mix: 10 More Articles — May 19, 2026
This update features cannabis clinical updates May 2026 with 10 articles scored below the clinical relevance threshold. Topics include substance use patterns, regulatory developments, and emerging research. These cannabis clinical updates May 2026…
A relational agent for treating substance use in adults: A randomized controlled trial with a psychoeducational comparator.
A randomized controlled trial demonstrates that a smartphone-based digital intervention for substance use disorders achieved greater reductions in substance use occasions compared to psychoeducational content alone. This research supports the potential…
New ADAI Research: Cannabis-Related Problems and Clinical Experiences
New ADAI research highlights cannabis use disorder clinical education as crucial for healthcare providers. Many clinicians report feeling unprepared to manage cannabis-related problems effectively. This study emphasizes the need for enhanced provider…